Erydel Series B financing
Erydel, the drug delivery company specialized in delivery through autologous red blood cells, completed a €15m series B financing led by Genextra S.p.A., with existing investors Innogest SGR and Focus Gestioni SGR also participating.
Torch Partners acted as exclusive financial advisor to Erydel on the financing.
)
)